Back to Dashboard






Medpace Holdings, Inc. (MEDP)
Real-time intraday values
Market Overview
From:
To:
MEDP Intraday
No data available
SymbolMEDP
IPO DateAug 11, 2016
CEODr. August James Troendle M.D.
Full Time Employees6.6k
SectorHealthcare
IndustryDiagnostics & Research
CountryUnited States
ExchangeNasdaqGS
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | +2.32% | +15.16 US$ |
| 5 Days | +8.19% | +50.65 US$ |
| 1 Month | +8.42% | +51.97 US$ |
| 6 Months | +62.99% | +258.58 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of MEDP...
Key Statistics
Market Cap
18.72B
P/E Ratio
37.16
Div Yield
0.00%
52W High
$684.52
52W Low
$373.00
Analyst Consensus
ConsensusHold
Bullish214.3%
Neutral1178.6%
Bearish17.1%
52W Analyst Price Targets
Min Target
$370.00
$370.00
Max Target
$730.00
$730.00
Current$669.12
Avg Target$644.77
Analyst Recommendations
Target Price:$644.77($370.00 - $730.00)
Community Thoughts
Share your analysis and sentiment on MEDP
Join the community to share your analysis
Latest News for MEDP

MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues
StockStory•Oct 23, 2026, 11:20 PM
Medpace's Bookings, Pre-Backlog Trends Support Growth Outlook, UBS Says
MT Newswires•Oct 23, 2026, 06:42 PM
UBS Adjusts Price Target on Medpace to $700 From $673, Maintains Neutral Rating
MT Newswires•Oct 23, 2026, 01:40 PM

Dow Jones Futures Fall After Moderna Crashes, Meta Fuels AI Meltdown. Warren Buffett Market Is Thriving.
Investor's Business Daily•Oct 23, 2026, 12:14 PM

5 revealing analyst questions from Medpace’s Q3 earnings call
StockStory•Oct 23, 2026, 11:12 AM
Truist Securities Adjusts Price Target on Medpace Holdings to $633 From $609, Keeps Hold Rating
MT Newswires•Oct 23, 2026, 09:45 AM

Does Medpace Holdings (MEDP) Leave Any Room For Cash Flow Upside?
Simply Wall St.•Oct 23, 2026, 06:17 AM

Medpace: 3 Key Takeaways for Long-Term Investors
Motley Fool•Oct 23, 2026, 04:11 AM

Medpace Holdings (MEDP) Beat Q3 Estimates, Is It Still 24% Overvalued?
Simply Wall St.•Oct 22, 2026, 10:10 PM
Medpace Holdings Inc (MEDP) (Q3 2026) Earnings Call Highlights: Record Awards and Margin ...
GuruFocus.com•Oct 22, 2026, 09:04 PM